"Editor’s note: An earlier version of this article stated that people with compromised immunity are at greater risk of contracting the coronavirus, in addition to developing more serious disease. While this is the case for many infections, there currently are not enough data to say whether immunocompromised people, including those living with HIV, are at greater risk of catching the new virus."

Read the full article at  https://www.poz.com/article/...

2020 CFAR NIH Administrative Supplement Opportunity

Support for innovative research projects, inter-CFAR meetings, and shared instrumentation that address key gaps in HIV/AIDS and will advance the field. This opportunity should build research capacity and be consistent with the recent NIH HIV/AIDS research priorities (NOT-OD-15-137).

The NIH is interested in supplement applications from CFARs in the following areas:

• Methodology and Data Science of HIV
• Increasing the Integration of Substance Abuse Services and HIV Prevention and Care...

National Black HIV/AIDS Awareness Day (NBHAAD)

National Black HIV/AIDS Awareness Day is being observed this year on Friday, February 7. This year’s NBHAAD theme, “Together for Love: Stop HIV Stigma,” highlights the messages of the CDC’s Let’s Stop HIV Together campaign. According to CDC, the campaign is designed to raise awareness that we all have a role to play in stopping HIV stigma within the Black community.

CDC’s latest HIV surveillance data:

•             In 2018, Blacks/African...

The ATN is pleased to announce a new Request for Proposals (RFP) for research aimed at Ending the HIV Epidemic: A Plan for America.

View the RFP here or in the attached PDF.

The purpose of...

Photo by Sarah Graham

"Dr. Lisa Bebell works with research nurse Honest Twinomujuni to record data on postpartum sepsis in Mbarara, Uganda."

Lisa Bebell, M.D.

• Fogarty Fellow:
  2005-2006 and 2014-2015
• ...

In honor of national Transgender Day of Remembrance, the Multicultural AIDS Coalition & Harvard University Center for AIDS Research is excited to present the debut of SHERO Talks: Virtual Journal Club Series. SHERO Talks, is a podcast series where trans women of color speak on their health,...

Robert H. Goldstein, M.D., Ph.D., and Rochelle P. Walensky, M.D., M.P.H. explain what happened with the Gilead Sciences DISCOVER trial and why it failed cisgender women and people everywhere.

From the article:
"Two months after its approval for treatment, F/TAF’s manufacturer, Gilead Sciences, moved forward with an effort to expand the drug’s indications to include prevention of HIV infection. To do so, they collaborated with researchers, community members, and the FDA to develop a new preexposure prophylaxis trial protocol — the DISCOVER trial — and to work...

September 2019 DAIDS Council-Approved Concepts

Dr. Ingrid Bassett, HU CFAR Developmental and Mentoring Core Director, was a plenary speaker at IAS 2019 in Mexico City. 

"The 10th IAS Conference on HIV Science (IAS 2019) was notable to me for two reasons. Firstly, it was a shift away from the 90-90-90 national targets to a more nuanced awareness of which populations are not being reached with existing HIV services. Secondly, differentiated service delivery (DSD) models were applied not...